QQ客服 官方微博 反馈留言

浏览/检索结果: 共9条，第1-9条 帮助 限定条件 发表日期：2020     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Beyond Blocking: Engineering RNAi-Mediated Targeted Immune Checkpoint Nanoblocker Enables T-Cell-lndependent Cancer Treatment 期刊论文 ACS NANO, 2020, 卷号: 14 作者:  Han, Xiaoyan;  Wang, Linlin;  Li, Ting;  Zhang, Jiahui;  Zhang, Dailiang 收藏  |  浏览/下载：54/0  |  提交时间：2021/03/15 immune checkpoint blockade  RNAi engineering  nanostructure  NSCLC  cancer immunotherapy   Ternary Regulation of Tumor Microenvironment by Heparanase-Sensitive Micelle-Loaded Monocytes Improves Chemo-Immunotherapy of Metastatic Breast Cancer 期刊论文 ADVANCED FUNCTIONAL MATERIALS, 2020, 页码: 12 作者:  Lang, Tianqun;  Zheng, Zhong;  Huang, Xin;  Liu, Yiran;  Zhai, Yihui 收藏  |  浏览/下载：86/0  |  提交时间：2021/05/24 breast cancer  chemo-immunotherapy  heparinase  monocytes  tumor environments   Immune Checkpoint Blockade in Cancer Immunotherapy: Mechanisms, Clinical Outcomes, and Safety Profiles of PD-1/PD-L1 Inhibitors 期刊论文 ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2020, 卷号: 68, 期号: 6, 页码: 15 作者:  Yan, Yan;  Zhang, Li;  Zuo, Yun;  Qian, Heya;  Liu, Chang 收藏  |  浏览/下载：20/0  |  提交时间：2021/05/24 Immune checkpoints  PD-1  PD-L1  Monoclonal antibody  Immunotherapy   Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen 期刊论文 NATURE BIOMEDICAL ENGINEERING, 2020, 页码: 19 作者:  Xie, Xiaoling;  Hu, Yuxing;  Ye, Tong;  Chen, Yiran;  Zhou, Lijuan 收藏  |  浏览/下载：17/0  |  提交时间：2021/03/29 PD-1 inhibitor combined with apatinib for advanced gastric or esophagogastric junction cancer: a retrospective study 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Wei, Qing;  Yuan, Xing;  Li, Jingjing;  Xu, Qi;  Ying, Jieer 收藏  |  浏览/下载：30/0  |  提交时间：2020/11/30 Programmed death 1 (PD-1)  gastric cancer (GC)  immune checkpoint inhibitors  immunotherapy  apatinib   Primary pulmonary lymphoepithelioma-like carcinoma 期刊论文 MEDICAL ONCOLOGY, 2020, 卷号: 37 作者:  Fan, Ying;  Li, Chenghui;  Qin, Jing;  Lu, Hongyang 收藏  |  浏览/下载：18/0  |  提交时间：2020/11/26 PPLELC  Clinical features  Molecular characteristics  Treatment  PD-L1  Prognosis   Combination Immunotherapy with Cytotoxic T-Lymphocyte-Associated Antigen-4 and Programmed Death Protein-1 Inhibitors Prevents Postoperative Breast Tumor Recurrence and Metastasis 期刊论文 MOLECULAR CANCER THERAPEUTICS, 2020, 卷号: 19, 期号: 3, 页码: 802-811 作者:  Sun, Ting;  Zhang, Wenjia;  Li, Yuan;  Jin, Zhengyu;  Du, Yang 收藏  |  浏览/下载：19/0  |  提交时间：2020/04/07 Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma 期刊论文 JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 卷号: 8, 期号: 2, 页码: 15 作者:  He, Xiran;  Du, Yang;  Wang, Zhijie;  Wang, Xin;  Duan, Jianchun 收藏  |  浏览/下载：29/0  |  提交时间：2021/01/06 drug therapy  combination  immunotherapy  lung neoplasms  lymphocytes  tumor-infiltrating  translational medical research   Small-molecule PD-L1 inhibitor BMS1166 abrogates the function of PD-L1 by blocking its ER export 期刊论文 ONCOIMMUNOLOGY, 2020, 卷号: 9, 期号: 1, 页码: 11 作者:  Chen, Fang-Fang;  Li, Zheng;  Ma, Dawei;  Yu, Qiang 收藏  |  浏览/下载：19/0  |  提交时间：2020/12/24 BMS1166  PD-L1  PD-1  glycosylation  ER export